跳到正文

Bernstein Harold 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Bernstein Harold(CIK 2050172)在 1 家公司共报告 45 笔 SEC Form 4 内部人交易(最近一笔 2026-10-02)。

日期公司身份类型股数市值
2026-10-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入16,141$168,189
2026-10-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出16,141$434,743
2026-09-08Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出9,705$254,502
2026-09-04Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出4,481$118,191
2026-09-04Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出625$16,951
2026-09-04Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出5,130$133,448
2026-09-04Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出59$1,521
2026-09-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入16,141$168,189
2026-09-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出16,141$425,512
2026-09-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入20,000$0
2026-08-14Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入16,142$168,200
2026-08-14Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出16,142$445,621
2026-07-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入14,609$152,226
2026-07-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出13,409$400,460
2026-07-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出1,200$36,404
2026-06-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入14,853$154,768
2026-06-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出13,253$338,879
2026-06-03Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出1,600$42,176
2026-05-18Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入15,000$156,300
2026-05-18Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出15,000$393,300
2026-04-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入15,000$156,300
2026-04-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出11,352$331,932
2026-04-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出3,348$100,641
2026-04-02Maze Therapeutics, Inc. (MAZE)President, R&D & CMO卖出300$9,321
2026-03-20Maze Therapeutics, Inc. (MAZE)President, R&D & CMO买入15,000$156,300

来源:SEC Form 4 申报文件 · 截至 2026-10-02